logo-loader
viewAvacta Group PLC

'The small cap pharma cream now rising to the top' after initial wave of interest - Zak Mir

Market Commentator Zak Mir says similar to the dot com bubble, people have now become more fussy when it comes to small cap pharma stocks after the initial wave of interest which saw the tide push the majority of share prices higher.

''Now the trick is to try to work out who the leaders are in the pack - it may be the likes of Avacta (LON:AVCT), Novacyt (LON:NCYT), Omega Diagnostics (LON:ODX) - the cream is rising to the top'', he says.

''If you get it wrong you'll be 30-50% offside from the peaks ... but if you get it right the shares will hold most of their gains and you'll have a reasonable ride''.

''We still don't know on a fundamental basis who's going to win ... whether it'll be the antigen people, the antibody people, the PPE people .. treatment, cure, vaccine ... it's all up in the air''.

He says we're getting back to some a semblance of normality in the markets but at the same time many more people are joining the twitter party - new names, new traders - and says, like some are suggesting, people could be putting some of their furlough money into the market, sitting at home and clicking away.

''If you like small caps it's actually a very good time and a much more positive time than you would've anticipated''.

Quick facts: Avacta Group PLC

Price: 139 GBX

AIM:AVCT
Market: AIM
Market Cap: £346.33 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Avacta Group PLC named herein, including the promotion by the Company of Avacta Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon outlines collaboration with Avacta for real-time...

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated...

3 weeks, 6 days ago

2 min read